Syntara Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.694x

Syntara Ltd cash flow conversion efficiency. Based on the latest financial reports, Syntara Ltd (SNT) has a cash flow conversion efficiency ratio of -0.694x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.12 Million ≈ $-7.86 Million USD) by net assets (AU$16.02 Million ≈ $11.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Syntara Ltd (2004–2023)

Cash flow conversion efficiency of Syntara Ltd from 2004 to 2023. This chart illustrates how Syntara Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Syntara Ltd stock quote for real-time trading data and today's change.

Syntara Ltd Cash Flow Conversion Ratio Explained

Syntara Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Syntara Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syntara Ltd ranked by their cash flow conversion efficiency. Also see SNT company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Uniserve Communications Corp
V:USS
-0.071x
Cruzados SADP
SN:CRUZADOS
-0.021x
Kintech Electronics Co Ltd
TWO:6210
-0.056x
Mountain Alliance AG
XETRA:ECF
-0.020x
Eastparc Hotel Tbk PT
JK:EAST
0.017x
MegaMD Co. Ltd
KQ:133750
-0.005x
Deep Value Driller AS
OL:DVD
1.304x
Milestone Scientific
NYSE MKT:MLSS
0.032x

Annual Cash Flow Conversion Efficiency for Syntara Ltd (2004–2023)

The table below shows the annual cash flow conversion efficiency of Syntara Ltd from 2004 to 2023. Review SNT free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-06-30 AU$9.56 Million
≈ $6.76 Million
AU$-7.28 Million
≈ $-5.15 Million
-0.761x +49.55%
2022-06-30 AU$10.80 Million
≈ $7.64 Million
AU$-16.30 Million
≈ $-11.54 Million
-1.509x -239.75%
2021-06-30 AU$2.85 Million
≈ $2.01 Million
AU$3.07 Million
≈ $2.17 Million
1.080x +111.63%
2020-06-30 AU$1.43 Million
≈ $1.01 Million
AU$-13.28 Million
≈ $-9.40 Million
-9.283x -594.61%
2019-06-30 AU$14.81 Million
≈ $10.48 Million
AU$-19.80 Million
≈ $-14.01 Million
-1.336x -221.73%
2018-06-30 AU$11.12 Million
≈ $7.87 Million
AU$12.21 Million
≈ $8.64 Million
1.098x +125.33%
2017-06-30 AU$3.52 Million
≈ $2.49 Million
AU$-15.26 Million
≈ $-10.80 Million
-4.335x -656.57%
2016-06-30 AU$20.93 Million
≈ $14.81 Million
AU$-11.99 Million
≈ $-8.48 Million
-0.573x -195.54%
2015-06-30 AU$36.32 Million
≈ $25.70 Million
AU$21.78 Million
≈ $15.41 Million
0.600x +138.51%
2014-06-30 AU$18.07 Million
≈ $12.78 Million
AU$-28.13 Million
≈ $-19.91 Million
-1.557x -198.78%
2013-06-30 AU$67.89 Million
≈ $48.04 Million
AU$-35.38 Million
≈ $-25.04 Million
-0.521x -50.03%
2012-06-30 AU$109.80 Million
≈ $77.69 Million
AU$-38.14 Million
≈ $-26.99 Million
-0.347x +34.15%
2011-06-30 AU$70.83 Million
≈ $50.12 Million
AU$-37.37 Million
≈ $-26.44 Million
-0.528x -52.90%
2010-06-30 AU$115.02 Million
≈ $81.38 Million
AU$-39.68 Million
≈ $-28.08 Million
-0.345x -79.48%
2009-06-30 AU$137.69 Million
≈ $97.43 Million
AU$-26.47 Million
≈ $-18.73 Million
-0.192x -21.48%
2008-06-30 AU$119.12 Million
≈ $84.29 Million
AU$-18.85 Million
≈ $-13.34 Million
-0.158x +41.47%
2007-06-30 AU$76.56 Million
≈ $54.17 Million
AU$-20.70 Million
≈ $-14.64 Million
-0.270x -94.07%
2006-06-30 AU$98.89 Million
≈ $69.97 Million
AU$-13.78 Million
≈ $-9.75 Million
-0.139x +46.58%
2005-06-30 AU$35.57 Million
≈ $25.17 Million
AU$-9.27 Million
≈ $-6.56 Million
-0.261x -50.10%
2004-06-30 AU$26.78 Million
≈ $18.95 Million
AU$-4.65 Million
≈ $-3.29 Million
-0.174x --

About Syntara Ltd

AU:SNT Australia Drug Manufacturers - Specialty & Generic
Market Cap
$20.80 Million
AU$29.39 Million AUD
Market Cap Rank
#24788 Global
#1009 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$0.40
About

Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product candidate, amsulostat, is being developed for the treatment of bone marrow cancer myelofibrosis and i… Read more